Search by Drug Name or NDC
NDC 62135-0321-18 Methyldopa 250 mg/1 Details
Methyldopa 250 mg/1
Methyldopa is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Chartwell RX, LLC. The primary component is METHYLDOPA.
Product Information
| NDC | 62135-0321 |
|---|---|
| Product ID | 62135-321_f174f4ef-f4e1-315d-e053-2a95a90a85a6 |
| Associated GPIs | |
| GCN Sequence Number | 000361 |
| GCN Sequence Number Description | methyldopa TABLET 250 MG ORAL |
| HIC3 | A4B |
| HIC3 Description | ANTIHYPERTENSIVES, SYMPATHOLYTIC |
| GCN | 01431 |
| HICL Sequence Number | 000118 |
| HICL Sequence Number Description | METHYLDOPA |
| Brand/Generic | Generic |
| Proprietary Name | Methyldopa |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Methyldopa |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, FILM COATED |
| Route | ORAL |
| Active Ingredient Strength | 250 |
| Active Ingredient Units | mg/1 |
| Substance Name | METHYLDOPA |
| Labeler Name | Chartwell RX, LLC |
| Pharmaceutical Class | Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA018934 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 62135-0321-18 (62135032118)
| NDC Package Code | 62135-321-18 |
|---|---|
| Billing NDC | 62135032118 |
| Package | 180 TABLET, FILM COATED in 1 BOTTLE (62135-321-18) |
| Marketing Start Date | 2022-11-22 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |